Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease-authors' reply.

Autor:	Mahmoud R; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Schultheiss JPD; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Fidder HH; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Oldenburg B; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Jazyk:	angličtina
Zdroj:	Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Feb; Vol. 55 (4), pp. 499-500.
DOI:	10.1111/apt.16757
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.